News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
814,353 Results
Type
Article (74257)
Company Profile (643)
Press Release (739453)
Multimedia
Podcasts (122)
Webinars (14)
Section
Business (226385)
Career Advice (3718)
Deals (39131)
Drug Delivery (129)
Drug Development (88933)
Employer Resources (198)
FDA (17765)
Job Trends (17096)
News (385841)
Policy (38600)
Tag
Academia (2999)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (94)
Alliances (55781)
ALS (99)
Alzheimer's disease (1501)
Antibody-drug conjugate (ADC) (156)
Approvals (17730)
Artificial intelligence (302)
Autoimmune disease (28)
Automation (16)
Bankruptcy (402)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (440)
Bladder cancer (85)
Brain cancer (32)
Breast cancer (301)
Cancer (2431)
Cardiovascular disease (204)
Career advice (3167)
Career pathing (34)
CAR-T (173)
Cell therapy (480)
Cervical cancer (21)
Clinical research (71850)
Collaboration (910)
Company closure (1)
Compensation (552)
Complete response letters (30)
COVID-19 (2866)
CRISPR (48)
C-suite (265)
Cystic fibrosis (107)
Data (2267)
Decentralized trials (2)
Denatured (40)
Depression (55)
Diabetes (297)
Diagnostics (6915)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (132)
Drug pricing (127)
Drug shortages (33)
Duchenne muscular dystrophy (101)
Earnings (93261)
Editorial (45)
Employer branding (25)
Employer resources (167)
Events (128745)
Executive appointments (773)
FDA (19095)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (809)
Gene editing (119)
Generative AI (28)
Gene therapy (354)
GLP-1 (851)
Government (5109)
Grass and pollen (6)
Guidances (67)
Healthcare (20869)
Huntington's disease (25)
IgA nephropathy (31)
Immunology and inflammation (146)
Indications (30)
Infectious disease (3026)
Inflammatory bowel disease (153)
Inflation Reduction Act (11)
Influenza (56)
Intellectual property (101)
Interviews (726)
IPO (17713)
IRA (51)
Job creations (4950)
Job search strategy (2591)
Kidney cancer (11)
Labor market (42)
Layoffs (555)
Leadership (24)
Legal (9876)
Liver cancer (81)
Lung cancer (345)
Lymphoma (159)
Machine learning (7)
Management (65)
Manufacturing (345)
MASH (75)
Medical device (14618)
Medtech (14623)
Mergers & acquisitions (21963)
Metabolic disorders (788)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (113)
Neuropsychiatric disorders (34)
Neuroscience (2104)
NextGen: Class of 2025 (7633)
Non-profit (5080)
Now hiring (40)
Obesity (425)
Opinion (275)
Ovarian cancer (78)
Pain (99)
Pancreatic cancer (86)
Parkinson's disease (160)
Partnered (22)
Patents (250)
Patient recruitment (116)
Peanut (51)
People (63852)
Pharmaceutical (132)
Pharmacy benefit managers (21)
Phase I (22219)
Phase II (31342)
Phase III (23638)
Pipeline (1255)
Policy (172)
Postmarket research (3236)
Preclinical (9788)
Press Release (72)
Prostate cancer (113)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (429)
Real estate (7125)
Recruiting (75)
Regulatory (25934)
Reports (57)
Research institute (2655)
Resumes & cover letters (579)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (81)
Series A (143)
Series B (91)
Service/supplier (26)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (165)
Sponsored (34)
Startups (4195)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (46)
The Weekly (80)
Vaccines (813)
Venture capitalists (44)
Weight loss (304)
Women's health (37)
Worklife (20)
Date
Today (35)
Last 7 days (944)
Last 30 days (2727)
Last 365 days (35169)
2025 (11564)
2024 (37892)
2023 (42567)
2022 (53926)
2021 (58722)
2020 (57663)
2019 (51302)
2018 (39084)
2017 (36794)
2016 (37687)
2015 (43673)
2014 (38217)
2013 (34170)
2012 (36130)
2011 (36197)
2010 (35487)
Location
Africa (1187)
Alabama (60)
Alaska (7)
Arizona (244)
Arkansas (14)
Asia (48221)
Australia (8290)
California (6437)
Canada (2062)
China (562)
Colorado (284)
Connecticut (301)
Delaware (158)
Europe (109503)
Florida (942)
Georgia (220)
Hawaii (1)
Idaho (63)
Illinois (622)
India (30)
Indiana (332)
Iowa (12)
Japan (168)
Kansas (110)
Kentucky (28)
Louisiana (14)
Maine (70)
Maryland (967)
Massachusetts (4940)
Michigan (246)
Minnesota (420)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (65)
New Hampshire (69)
New Jersey (1822)
New Mexico (31)
New York (1824)
North Carolina (1124)
North Dakota (9)
Northern California (2752)
Ohio (219)
Oklahoma (15)
Oregon (46)
Pennsylvania (1421)
Puerto Rico (13)
Rhode Island (36)
South America (1562)
South Carolina (24)
South Dakota (1)
Southern California (2384)
Tennessee (104)
Texas (956)
United States (24693)
Utah (191)
Virginia (170)
Washington D.C. (70)
Washington State (601)
West Virginia (3)
Wisconsin (68)
814,353 Results for "genecast biotechnology co".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Battelle and Allonnia to Co-Host 2025 Bioremediation and Environmental Biotechnology Conference
Battelle is pleased to announce that it will co-host the Seventh International Symposium on Bioremediation and Environmental Biotechnology with Allonnia.
June 3, 2024
·
2 min read
Press Releases
Satellos to Present at Bloom Burton & Co. Healthcare Investor Conference
April 29, 2025
·
1 min read
Biotech Beach
LIXTE Biotechnology Co-Sponsoring International Scientific Conference on “Therapeutic Over-Activation in Cancer”
LIXTE Biotechnology Holdings, Inc. announced it is co-sponsoring an international scientific workshop on “Therapeutic Over-Activation in Cancer” at Harvard University’s Dana Farber Cancer Institute on May 9 and 10, 2024 in Boston, Massachusetts.
May 8, 2024
·
4 min read
Press Releases
Aptose to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
April 23, 2025
·
3 min read
Press Releases
STX PARTNERS LLP and Newlin Investment Co. Exercise Warrants of Sharp Therapeutics Corp.
April 21, 2025
·
3 min read
Press Releases
Marvel Presenting at the 2025 Bloom Burton & Co. Conference
March 11, 2025
·
4 min read
Press Releases
Ventus Therapeutics to Present at 2025 Bloom Burton & Co. Healthcare Investor Conference
April 29, 2025
·
1 min read
Press Releases
Medicenna to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
April 23, 2025
·
4 min read
Press Releases
Ferrer Enters Into a Collaboration and License Agreement With Prilenia for the Commercialization and Co-Development of Pridopidine
April 28, 2025
·
3 min read
Press Releases
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast
April 29, 2025
·
1 min read
1 of 81,436
Next
